GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (FRA:MD1) » Definitions » Cyclically Adjusted PS Ratio

Medistim ASA (FRA:MD1) Cyclically Adjusted PS Ratio : 7.68 (As of Jun. 02, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Medistim ASA Cyclically Adjusted PS Ratio?

As of today (2025-06-02), Medistim ASA's current share price is €16.75. Medistim ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was €2.18. Medistim ASA's Cyclically Adjusted PS Ratio for today is 7.68.

The historical rank and industry rank for Medistim ASA's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:MD1' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.75   Med: 11.04   Max: 23.03
Current: 7.85

During the past years, Medistim ASA's highest Cyclically Adjusted PS Ratio was 23.03. The lowest was 4.75. And the median was 11.04.

FRA:MD1's Cyclically Adjusted PS Ratio is ranked worse than
82.61% of 483 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs FRA:MD1: 7.85

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medistim ASA's adjusted revenue per share data for the three months ended in Mar. 2025 was €0.859. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €2.18 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medistim ASA Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Medistim ASA's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medistim ASA Cyclically Adjusted PS Ratio Chart

Medistim ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.10 20.91 11.56 9.55 6.13

Medistim ASA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.12 7.24 7.48 6.13 6.91

Competitive Comparison of Medistim ASA's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Medistim ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medistim ASA's Cyclically Adjusted PS Ratio falls into.


;
;

Medistim ASA Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Medistim ASA's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=16.75/2.18
=7.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medistim ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Medistim ASA's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.859/136.1000*136.1000
=0.859

Current CPI (Mar. 2025) = 136.1000.

Medistim ASA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.361 100.100 0.491
201509 0.366 100.600 0.495
201512 0.426 100.900 0.575
201603 0.382 102.500 0.507
201606 0.397 103.800 0.521
201609 0.407 104.200 0.532
201612 0.379 104.400 0.494
201703 0.450 105.000 0.583
201706 0.401 105.800 0.516
201709 0.446 105.900 0.573
201712 0.430 106.100 0.552
201803 0.426 107.300 0.540
201806 0.443 108.500 0.556
201809 0.444 109.500 0.552
201812 0.529 109.800 0.656
201903 0.502 110.400 0.619
201906 0.529 110.600 0.651
201909 0.474 111.100 0.581
201912 0.487 111.300 0.596
202003 0.501 111.200 0.613
202006 0.422 112.100 0.512
202009 0.424 112.900 0.511
202012 0.452 112.900 0.545
202103 0.555 114.600 0.659
202106 0.593 115.300 0.700
202109 0.550 117.500 0.637
202112 0.557 118.900 0.638
202203 0.653 119.800 0.742
202206 0.624 122.600 0.693
202209 0.625 125.600 0.677
202212 0.711 125.900 0.769
202303 0.627 127.600 0.669
202306 0.642 130.400 0.670
202309 0.593 129.800 0.622
202312 0.644 131.900 0.665
202403 0.633 132.600 0.650
202406 0.692 133.800 0.704
202409 0.615 133.700 0.626
202412 0.702 134.800 0.709
202503 0.859 136.100 0.859

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medistim ASA  (FRA:MD1) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Medistim ASA Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Medistim ASA's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medistim ASA Business Description

Traded in Other Exchanges
Address
Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.

Medistim ASA Headlines

No Headlines